ArticleTheranostics2021

MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.

Qiji Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.